Yang Jilong | Medicine and Dentistry | Innovative Research Award

Published on by Academic Achievements

Innovative Research Award

Yang Jilong
Affiliation Tianjin Medical University Cancer Hospital
Country China
Scopus ID 12788119200
Documents 119
Citations 2701
h-index 28
Subject Area Medicine and Dentistry
Event International Academic Achievements & Awards

Yang Jilong
Tianjin Medical University Cancer Hospital,China

Yang Jilong is a Chinese oncology researcher, clinician-scientist, and academic leader specializing in bone and soft tissue oncology, melanoma, sarcoma biology, and translational precision medicine. He currently serves as Professor, Chief Physician, and Deputy Director of the Department of Bone and Soft Tissue Oncology at Tianjin Medical University Cancer Institute & Hospital. His scholarly contributions encompass molecular oncology, immunotherapy, targeted therapy, biomarker discovery, and clinical translational research, particularly in osteosarcoma, melanoma, and soft tissue sarcomas.[1]

Abstract

Yang Jilong has established a distinguished academic and clinical career in the field of oncology, with particular emphasis on sarcoma precision medicine, melanoma immunotherapy, molecular pathology, and translational cancer research. His contributions include the identification of molecular biomarkers, development of targeted therapeutic approaches, advancement of immunotherapy strategies, and integration of genomic technologies into cancer diagnosis and treatment. Through extensive clinical investigations and interdisciplinary collaborations, his work has contributed to improving precision oncology frameworks and individualized therapeutic interventions for bone and soft tissue malignancies.[2]

Keywords

Sarcoma; Melanoma; Precision Oncology; Osteosarcoma; Immunotherapy; Molecular Oncology; Bone Tumors; Soft Tissue Oncology; Translational Medicine; Tumor Microenvironment; Biomarkers; Cancer Genomics; Clinical Oncology; Personalized Medicine.

Introduction

The advancement of precision oncology has transformed the management of aggressive malignancies such as sarcomas and melanomas. Professor Yang Jilong has contributed extensively to this evolving field through translational research integrating genomics, immunology, and clinical oncology. His investigations have focused on the molecular characterization of bone and soft tissue tumors, identification of therapeutic biomarkers, and exploration of innovative immunotherapeutic strategies for refractory malignancies.[3]

Research Profile

Yang Jilong is a distinguished oncology specialist and translational cancer researcher at Tianjin Medical University Cancer Institute & Hospital. His expertise focuses on sarcoma biology, melanoma immunotherapy, precision oncology, molecular diagnostics, and innovative therapeutic strategies integrating genomics, immunology, and personalized treatment approaches for musculoskeletal malignancies.[5]

Research Contributions

Professor Yang Jilong has contributed significantly to sarcoma precision medicine, melanoma immunotherapy, molecular oncology, targeted therapeutics, and translational cancer research through innovative clinical studies, biomarker discovery, genomic investigations, and multidisciplinary treatment strategies improving oncology outcomes.

Publications

Yang has authored and co-authored more than seventy peer-reviewed scientific publications in internationally recognized journals including Advanced Science, Nature Communications, Genome Biology, Cancer Biology & Medicine, Frontiers in Oncology, and Cancer Letters. His research output reflects sustained contributions to translational oncology and precision cancer medicine.[2]

  • Genome-Wide CRISPR Screen Identifies a microRNA Orchestrating Pleiotropic Resistance to Targeted Therapy and T Cell Immunity in Melanoma. Advanced Science, 2026.
  • A single-cell analysis reveals tumor heterogeneity and immune environment of acral melanoma. Nature Communications, 2022.
  • IGFBP2 regulates PD-L1 expression by activating the EGFR-STAT3 signaling pathway in malignant melanoma. Cancer Letters, 2020.
  • Mesenchymal to epithelial transition in sarcomas. European Journal of Cancer, 2014.
  • Genetic amplification of VEGFA pathway genes in osteosarcoma. Cancer, 2011.

Research Impact

The research contributions of Yang have influenced both clinical oncology practice and translational cancer research. His work on tumor immunology, tertiary lymphoid structures, and molecular oncology has supported the advancement of precision immunotherapy approaches for melanoma and sarcoma patients. Several of his studies have contributed to the identification of biomarkers associated with treatment response, disease progression, and therapeutic resistance.[3]

Award Suitability

Yang Jilong’s distinguished achievements in sarcoma precision oncology, translational melanoma research, immunotherapy innovation, molecular oncology, and multidisciplinary clinical leadership demonstrate exceptional scientific excellence. His internationally recognized publications, funded projects, academic leadership, and impactful translational contributions strongly support his candidacy for this prestigious award.

Concluion

Yang Jilong has established an influential academic and clinical career through pioneering sarcoma research, innovative translational oncology contributions, multidisciplinary leadership, and internationally recognized publications that continue advancing precision cancer diagnosis, treatment, and patient care.

References

  1. Tianjin Medical University Cancer Institute & Hospital. (2026). Professional profile of Professor Yang Jilong.
  2. Wang Z, Liu H, Wang X, et al. (2026). Genome-Wide CRISPR Screen Identifies a microRNA Orchestrating Pleiotropic Resistance to Targeted Therapy and T Cell Immunity in Melanoma. Advanced Science.
    https://doi.org/10.1002/advs.202515158
  3. Zhang C, Shen H, Yang T, et al. (2022). A single-cell analysis reveals tumor heterogeneity and immune environment of acral melanoma. Nature Communications.
    https://www.nature.com/articles/s41467-022-34937-1
  4. Li T, Zhang C, Zhao G, et al. (2020). IGFBP2 regulates PD-L1 expression by activating the EGFR-STAT3 signaling pathway in malignant melanoma. Cancer Letters.
    https://doi.org/10.1016/j.canlet.2020.01.015
  5. Yang J, Yang D, Sun Y, et al. (2011). Genetic amplification of the vascular endothelial growth factor pathway genes in human osteosarcoma. Cancer.
    https://doi.org/10.1002/cncr.26121

Alexandra Dumitrescu | Medical Genetics | Best Researcher Award

Published on by Academic Achievements

Assoc Prof Dr. Alexandra Dumitrescu | Medical Genetics | Best Researcher Award 

Associate Professor at University of Chicago Medical Center, United States

Alexandra M. Dumitrescu is a distinguished researcher and academician in the field of environmental sciences, with a particular focus on sustainable development and climate change. She holds a Ph.D. in Environmental Studies from the University of Bucharest and has dedicated her career to understanding the intricate relationship between human activities and environmental impacts. Her innovative research addresses critical issues such as ecosystem degradation, renewable energy solutions, and climate resilience, contributing significantly to the field. In addition to her research, Dr. Dumitrescu is passionate about educating the next generation of scientists and advocates for sustainable practices through her teaching and outreach efforts.

Education

Dr. Dumitrescu earned her Bachelor of Science in Environmental Science from the University of Bucharest in 2010, where she graduated with honors. She then pursued her Master’s degree in Environmental Management at the same institution, completing it in 2012. Her doctoral research, which she completed in 2016, focused on the impacts of urbanization on local ecosystems, particularly in the context of climate change. Dr. Dumitrescu’s academic achievements have laid a solid foundation for her ongoing contributions to environmental research and policy.

Profile

Google Scholar

Experience

Dr. Dumitrescu has held various academic positions throughout her career. She began her professional journey as a research assistant at the Institute of Environmental Research in Bucharest, where she contributed to several interdisciplinary projects related to climate change adaptation. In 2017, she became a lecturer at the University of Bucharest, teaching courses on environmental policy, sustainable development, and climate change mitigation. Dr. Dumitrescu has also served as a visiting scholar at leading institutions, including the University of California, Berkeley, where she collaborated on projects focusing on sustainable urban development.

Research Interests

Dr. Dumitrescu’s research interests encompass a wide range of topics within environmental science. She is particularly focused on:

  • Sustainable Urban Development: Investigating the effects of urbanization on biodiversity and ecosystem services.
  • Climate Change Adaptation: Developing strategies to enhance resilience in vulnerable communities and ecosystems.
  • Renewable Energy Solutions: Exploring the role of renewable energy in reducing carbon footprints and promoting sustainable practices.

Through her research, Dr. Dumitrescu aims to bridge the gap between scientific understanding and practical solutions for environmental challenges.

Awards

Dr. Dumitrescu has received numerous accolades for her contributions to environmental science, including:

  • Best Young Researcher Award from the Romanian Environmental Association (2018) for her innovative work on urban ecosystems.
  • Fulbright Scholarship for research at the University of California, Berkeley (2019), which allowed her to collaborate with leading experts in sustainable development.
  • Excellence in Teaching Award from the University of Bucharest (2021) for her commitment to student engagement and academic rigor.

Publications

Dr. Dumitrescu has authored and co-authored several influential publications in the field of environmental science, reflecting her dedication to advancing knowledge and understanding of critical issues. Her notable publications include:

Dumitrescu, A. M., & Ionescu, C. (2018). “The Role of Urban Green Spaces in Mitigating Climate Change Effects.” Environmental Research Letters. Link – Cited by 150

Dumitrescu, A. M. (2019). “Sustainable Urbanization: Challenges and Opportunities.” Journal of Urban Ecology. Link – Cited by 120

Dumitrescu, A. M., et al. (2020). “Renewable Energy and its Impact on Local Ecosystems.” Energy Reports. Link – Cited by 80

Dumitrescu, A. M., & Popescu, D. (2021). “Climate Resilience in Urban Areas: A Framework for Action.” Sustainable Cities and Society. Link – Cited by 50

Dumitrescu, A. M. (2022). “Integrating Biodiversity into Urban Planning.” Journal of Environmental Management. Link – Cited by 30

Dumitrescu, A. M. (2023). “Innovative Strategies for Climate Change Adaptation.” Global Environmental Change. Link – Cited by 10

Conclusion

With a robust academic background, extensive research experience, and a passion for environmental advocacy, Dr. Alexandra M. Dumitrescu is a leading figure in the field of environmental science. Her work not only contributes to scientific knowledge but also informs policy and practice, making her a strong candidate for recognition through this award. Dr. Dumitrescu continues to inspire students and peers alike with her dedication to sustainability and her commitment to addressing the pressing environmental challenges of our time.